FDA to fast-track Pfizer/Sangamo gene therapy orphan drug
admin 17th May 2017 Uncategorised 0SB-525 is being developed to treat haemophilia A
More: FDA to fast-track Pfizer/Sangamo gene therapy orphan drug
Source: News
SB-525 is being developed to treat haemophilia A
More: FDA to fast-track Pfizer/Sangamo gene therapy orphan drug
Source: News
© 1994 - 2025 B.M. Pharmaceuticals